Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Intangibles (2016 - 2020)

United Therapeutics' Intangibles history spans 6 years, with the latest figure at $128.9 million for Q4 2019.

  • For Q4 2019, Intangibles fell 6.39% year-over-year to $128.9 million; the TTM value through Dec 2019 reached $128.9 million, down 6.39%, while the annual FY2019 figure was $128.9 million, 6.39% down from the prior year.
  • Intangibles for Q4 2019 was $128.9 million at United Therapeutics, down from $137.7 million in the prior quarter.
  • Across five years, Intangibles topped out at $137.7 million in Q4 2018 and bottomed at $6.5 million in Q4 2017.
  • The 3-year median for Intangibles is $128.9 million (2019), against an average of $91.0 million.
  • The largest annual shift saw Intangibles soared 2018.46% in 2018 before it fell 6.39% in 2019.
  • A 3-year view of Intangibles shows it stood at $6.5 million in 2017, then skyrocketed by 2018.46% to $137.7 million in 2018, then fell by 6.39% to $128.9 million in 2019.
  • Per Business Quant, the three most recent readings for UTHR's Intangibles are $128.9 million (Q4 2019), $137.7 million (Q4 2018), and $6.5 million (Q4 2017).